PT - JOURNAL ARTICLE AU - Jules, Emmanuela AU - Decker, Charlie AU - Bixler, Brianna Jeanne AU - Ahmed, Alaa AU - Zhou, Zijing (Carol) AU - Arora, Itika AU - Tafesse, Henok AU - Dakanay, Hannah AU - Bombin, Andrei AU - Wang, Ethan AU - Ingersoll, Jessica AU - Bifulco, Kathy AU - Frediani, Jennifer K. AU - Parsons, Richard AU - Sullivan, Julie AU - Greenleaf, Morgan AU - Waggoner, Jesse J. AU - Martin, Greg S. AU - Lam, Wilbur A. AU - Piantadosi, Anne TI - Respiratory virus detection and sequencing from negative SARS-CoV-2 rapid antigen tests AID - 10.1101/2024.08.19.24311993 DP - 2024 Jan 01 TA - medRxiv PG - 2024.08.19.24311993 4099 - http://medrxiv.org/content/early/2024/08/20/2024.08.19.24311993.short 4100 - http://medrxiv.org/content/early/2024/08/20/2024.08.19.24311993.full AB - Genomic epidemiology offers important insight into the transmission and evolution of respiratory viruses. We used metagenomic sequencing from negative SARS-CoV-2 antigen tests to identify a wide range of respiratory viruses and generate full genome sequences, offering a streamlined mechanism for broad respiratory virus genomic surveillance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by NIH U54 EB027690 02S1, U54 EB027690 03S1, U54EB027690 03S2 UL1 TR002378 and the Centers for Disease Control and Prevention-funded Georgia Pathogen Genomics Center of Excellence contract 40500-050-23234506. This study was supported in part by the Emory Integrated Genomics Core (EIGC) (RRID:SCR_023529), which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities. Additional support was provided by the Georgia Clinical & Translational Science Alliance of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of Emory University and the Grady Research Oversight Committee gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll raw sequencing data (cleaned of human reads) is available in NCBI SRA under BioProject PRJNA634356, and assembled virus genome sequences are available in NCBI GenBank with accession numbers listed in the Supplementary Data file.